Anthem, Inc. is one of the premier healthcare service providers when it comes to providing medical and specialty products.
Already sporting one of the top position in the health insurance industry, the company is set to become a titan with the pending acquisition of another player Cigna Corp. Anthem is projected to become one of the top three health insurers. Also, the company is expected to witness significant earnings accretion from the deal.
The company has been working towards enhancing healthcare through the provision of reliable and superior quality services. The aforementioned deal is expected to help it in this regard.
However, adverse effect of the Health Insurance Provider (HIP) fee, increased financial leverage, higher medical costs in the Senior, Local Group and State-Sponsored businesses, lower favorable prior year reserve development and the impact of minimum medical loss ratio requirements are a drag.
Anthem has a decent history when it comes to earnings as the company has beaten estimates in three of the last four quarters, making for an average surprise of 4.1%.
Currently, Anthem holds a Zacks Rank #3 (Hold), but that could definitely change following its earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: Anthem beats on earnings. Our consensus called for EPS of $3.24, and the company reported EPS of $3.33.
Revenue: Operating revenues surpassed our estimate. Our consensus called for revenues of $20.4 billion, and the company reported revenues of $21.3 billion.
Key Stats to Note: Medical enrollment continues to impress us with a year over year increase of about 3.2%.
However, benefit expense ratio deteriorated 210 basis points year over year to 84.2%. The selling, general and administrative expense ratio was 14.0%, improving 140 basis points year over year.
Operating cash flow was $662 million, or 0.8 times net income.
The company expects net income to be greater than $9.34 per share, adjusted net income to be more than $10.80 per share, medical membership is expected to be in the range of 39.6 million – 39.8 million; operating revenue in the range of $82.5 – $83.5 billion in 2016.
Check back later for our full write up on this ANTM earnings report later!
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
Image: Bigstock
Anthem (ANTM) Q2 Earnings, Revenues Beat, Revises View
Anthem, Inc. is one of the premier healthcare service providers when it comes to providing medical and specialty products.
Already sporting one of the top position in the health insurance industry, the company is set to become a titan with the pending acquisition of another player Cigna Corp. Anthem is projected to become one of the top three health insurers. Also, the company is expected to witness significant earnings accretion from the deal.
The company has been working towards enhancing healthcare through the provision of reliable and superior quality services. The aforementioned deal is expected to help it in this regard.
However, adverse effect of the Health Insurance Provider (HIP) fee, increased financial leverage, higher medical costs in the Senior, Local Group and State-Sponsored businesses, lower favorable prior year reserve development and the impact of minimum medical loss ratio requirements are a drag.
Anthem has a decent history when it comes to earnings as the company has beaten estimates in three of the last four quarters, making for an average surprise of 4.1%.
Currently, Anthem holds a Zacks Rank #3 (Hold), but that could definitely change following its earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: Anthem beats on earnings. Our consensus called for EPS of $3.24, and the company reported EPS of $3.33.
ANTHEM INC Price and EPS Surprise
ANTHEM INC Price and EPS Surprise | ANTHEM INC Quote
Revenue: Operating revenues surpassed our estimate. Our consensus called for revenues of $20.4 billion, and the company reported revenues of $21.3 billion.
Key Stats to Note: Medical enrollment continues to impress us with a year over year increase of about 3.2%.
However, benefit expense ratio deteriorated 210 basis points year over year to 84.2%. The selling, general and administrative expense ratio was 14.0%, improving 140 basis points year over year.
Operating cash flow was $662 million, or 0.8 times net income.
The company expects net income to be greater than $9.34 per share, adjusted net income to be more than $10.80 per share, medical membership is expected to be in the range of 39.6 million – 39.8 million; operating revenue in the range of $82.5 – $83.5 billion in 2016.
Check back later for our full write up on this ANTM earnings report later!
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>